275 related articles for article (PubMed ID: 20068580)
1. Genetic determinants of cerebral vasospasm, delayed cerebral ischemia, and outcome after aneurysmal subarachnoid hemorrhage.
Ducruet AF; Gigante PR; Hickman ZL; Zacharia BE; Arias EJ; Grobelny BT; Gorski JW; Mayer SA; Connolly ES
J Cereb Blood Flow Metab; 2010 Apr; 30(4):676-88. PubMed ID: 20068580
[TBL] [Abstract][Full Text] [Related]
2. Associations between endothelin polymorphisms and aneurysmal subarachnoid hemorrhage, clinical vasospasm, delayed cerebral ischemia, and functional outcome.
Griessenauer CJ; Starke RM; Foreman PM; Hendrix P; Harrigan MR; Fisher WS; Vyas NA; Lipsky RH; Lin M; Walters BC; Pittet JF; Mathru M
J Neurosurg; 2018 May; 128(5):1311-1317. PubMed ID: 28548598
[TBL] [Abstract][Full Text] [Related]
3. Biomarker Discovery in Cerebral Vasospasm after Aneurysmal Subarachnoid Hemorrhage.
Przybycien-Szymanska MM; Ashley WW
J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1453-64. PubMed ID: 25957908
[TBL] [Abstract][Full Text] [Related]
4. Ryanodine Receptor 1 Polymorphism Is Not Associated with Aneurysmal Subarachnoid Hemorrhage or its Clinical Sequelae.
Hendrix P; Foreman PM; Harrigan MR; Fisher WS; Vyas NA; Lipsky RH; Lin M; Walters BC; Tubbs RS; Shoja MM; Pittet JF; Mathru M; Griessenauer CJ
World Neurosurg; 2017 Apr; 100():190-194. PubMed ID: 28087430
[TBL] [Abstract][Full Text] [Related]
5. To look beyond vasospasm in aneurysmal subarachnoid haemorrhage.
Cossu G; Messerer M; Oddo M; Daniel RT
Biomed Res Int; 2014; 2014():628597. PubMed ID: 24967389
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Cilostazol in Prevention of Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis.
Saber H; Desai A; Palla M; Mohamed W; Seraji-Bozorgzad N; Ibrahim M
J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):2979-2985. PubMed ID: 30093204
[TBL] [Abstract][Full Text] [Related]
7. Genetic Variability and Trajectories of DNA Methylation May Support a Role for HAMP in Patient Outcomes After Aneurysmal Subarachnoid Hemorrhage.
Heinsberg LW; Arockiaraj AI; Crago EA; Ren D; Shaffer JR; Sherwood PR; Sereika SM; Weeks DE; Conley YP
Neurocrit Care; 2020 Apr; 32(2):550-563. PubMed ID: 31346934
[TBL] [Abstract][Full Text] [Related]
8. Aneurysmal Subarachnoid Hemorrhage: Review of the Pathophysiology and Management Strategies.
Osgood ML
Curr Neurol Neurosci Rep; 2021 Jul; 21(9):50. PubMed ID: 34308493
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Statins in Cerebral Vasospasm, Mortality, and Delayed Cerebral Ischemia in Patients with Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Shen J; Shen J; Zhu K; Zhou H; Tian H; Yu G
World Neurosurg; 2019 Nov; 131():e65-e73. PubMed ID: 31295598
[TBL] [Abstract][Full Text] [Related]
10. Non-steroidal anti-inflammatory drugs in the pathophysiology of vasospasms and delayed cerebral ischemia following subarachnoid hemorrhage: a critical review.
Solar P; Mackerle Z; Joukal M; Jancalek R
Neurosurg Rev; 2021 Apr; 44(2):649-658. PubMed ID: 32124117
[TBL] [Abstract][Full Text] [Related]
11. Role of Genetic Polymorphisms in Predicting Delayed Cerebral Ischemia and Radiographic Vasospasm After Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis.
Rosalind Lai PM; Du R
World Neurosurg; 2015 Oct; 84(4):933-41.e2. PubMed ID: 26074429
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of haptoglobin genotype as a risk of cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
Ateia AM; Elbassiouny A; El-Nabi SH; Fahmy NA; Ibrahim MH; El-Garawani I; Geba KM; Khalaf M
Clin Neurol Neurosurg; 2020 Dec; 199():106296. PubMed ID: 33069930
[TBL] [Abstract][Full Text] [Related]
13. Effect of statin treatment on vasospasm, delayed cerebral ischemia, and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update.
Vergouwen MD; de Haan RJ; Vermeulen M; Roos YB
Stroke; 2010 Jan; 41(1):e47-52. PubMed ID: 19875741
[TBL] [Abstract][Full Text] [Related]
14. Vasospasm on transcranial Doppler is predictive of delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.
Kumar G; Shahripour RB; Harrigan MR
J Neurosurg; 2016 May; 124(5):1257-64. PubMed ID: 26495942
[TBL] [Abstract][Full Text] [Related]
15. New therapeutic approaches to subarachnoid hemorrhage.
Barry C; Turner RJ; Corrigan F; Vink R
Expert Opin Investig Drugs; 2012 Jun; 21(6):845-59. PubMed ID: 22530758
[TBL] [Abstract][Full Text] [Related]
16. Endothelial Cell Dysfunction and Injury in Subarachnoid Hemorrhage.
Peeyush Kumar T; McBride DW; Dash PK; Matsumura K; Rubi A; Blackburn SL
Mol Neurobiol; 2019 Mar; 56(3):1992-2006. PubMed ID: 29982982
[TBL] [Abstract][Full Text] [Related]
17. Endothelin-1 and endothelin receptor gene variants and their association with negative outcomes following aneurysmal subarachnoid hemorrhage.
Gallek M; Alexander S; Crago E; Sherwood P; Horowitz M; Poloyac S; Conley Y
Biol Res Nurs; 2013 Oct; 15(4):390-7. PubMed ID: 22997346
[TBL] [Abstract][Full Text] [Related]
18. Precision medicine of aneurysmal subarachnoid hemorrhage, vasospasm and delayed cerebral ischemia.
Burrell C; Avalon NE; Siegel J; Pizzi M; Dutta T; Charlesworth MC; Freeman WD
Expert Rev Neurother; 2016 Nov; 16(11):1251-1262. PubMed ID: 27314601
[TBL] [Abstract][Full Text] [Related]
19. Soluble Fms-Like Tyrosine Kinase 1 (sFlt-1) and Risk of Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage.
Griessenauer CJ; Chua MH; Hanafy KA; Baffour YT; Chen R; LeBlanc RH; Patel AS; Salem M; Karumanchi SA; Xu D; Thadhani R; Ogilvy CS; Thomas AJ
World Neurosurg; 2017 Dec; 108():84-89. PubMed ID: 28867315
[TBL] [Abstract][Full Text] [Related]
20. The pathophysiology and treatment of delayed cerebral ischaemia following subarachnoid haemorrhage.
Budohoski KP; Guilfoyle M; Helmy A; Huuskonen T; Czosnyka M; Kirollos R; Menon DK; Pickard JD; Kirkpatrick PJ
J Neurol Neurosurg Psychiatry; 2014 Dec; 85(12):1343-53. PubMed ID: 24847164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
